| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,397 |
1,286 |
$126K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
488 |
449 |
$65K |
| 70450 |
Computed tomography, head or brain; without contrast material |
153 |
146 |
$58K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
607 |
583 |
$34K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
78 |
77 |
$32K |
| 71046 |
Radiologic examination, chest; 2 views |
406 |
382 |
$29K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
755 |
188 |
$24K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
234 |
229 |
$21K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
18 |
17 |
$17K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
283 |
255 |
$16K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,595 |
1,237 |
$16K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
164 |
41 |
$11K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
44 |
42 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
208 |
204 |
$8K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
205 |
203 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
198 |
180 |
$8K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
307 |
287 |
$8K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
203 |
200 |
$8K |
| 80053 |
Comprehensive metabolic panel |
962 |
820 |
$8K |
| 71045 |
Radiologic examination, chest; single view |
200 |
189 |
$8K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
38 |
37 |
$8K |
| 36415 |
Collection of venous blood by venipuncture |
1,937 |
1,487 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,094 |
926 |
$6K |
| G0378 |
Hospital observation service, per hour |
30 |
14 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
375 |
319 |
$6K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
616 |
280 |
$6K |
| J3490 |
Unclassified drugs |
690 |
523 |
$5K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
141 |
84 |
$5K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
109 |
102 |
$5K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
101 |
101 |
$5K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
210 |
183 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
129 |
124 |
$4K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
51 |
48 |
$4K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
75 |
69 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
181 |
168 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
592 |
520 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
165 |
150 |
$3K |
| 73630 |
|
31 |
31 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
111 |
99 |
$3K |
| 84443 |
Thyroid stimulating hormone (TSH) |
246 |
235 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
353 |
329 |
$2K |
| 87088 |
|
352 |
328 |
$2K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
87 |
67 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
194 |
180 |
$2K |
| 73610 |
|
35 |
31 |
$2K |
| 87653 |
|
53 |
53 |
$2K |
| 81001 |
|
718 |
660 |
$2K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
33 |
24 |
$2K |
| 80061 |
Lipid panel |
223 |
217 |
$2K |
| 84484 |
|
199 |
156 |
$2K |
| 85027 |
|
409 |
375 |
$2K |
| 81025 |
|
200 |
199 |
$2K |
| 80055 |
|
25 |
25 |
$1K |
| 87634 |
|
29 |
29 |
$1K |
| 84439 |
|
186 |
179 |
$1K |
| 83690 |
|
190 |
179 |
$1K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
65 |
59 |
$1K |
| 74018 |
|
12 |
12 |
$969.19 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$889.20 |
| 87186 |
|
169 |
153 |
$867.60 |
| 87077 |
|
172 |
156 |
$827.03 |
| 80050 |
General health panel |
14 |
14 |
$693.85 |
| J2704 |
Injection, propofol, 10 mg |
37 |
36 |
$686.15 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
44 |
43 |
$676.13 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
148 |
145 |
$627.88 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
82 |
74 |
$543.61 |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
13 |
13 |
$519.96 |
| 85610 |
|
196 |
129 |
$465.83 |
| A9270 |
Non-covered item or service |
30 |
12 |
$459.93 |
| 97161 |
|
12 |
12 |
$403.61 |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
12 |
12 |
$371.60 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
72 |
72 |
$340.44 |
| 83880 |
|
12 |
12 |
$340.36 |
| 97162 |
|
12 |
12 |
$291.72 |
| 82948 |
|
97 |
62 |
$226.02 |
| 83735 |
|
52 |
38 |
$210.16 |
| 87040 |
|
30 |
14 |
$206.48 |
| 83605 |
|
29 |
26 |
$205.68 |
| 82947 |
|
46 |
46 |
$203.70 |
| 82728 |
|
15 |
13 |
$186.45 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
14 |
13 |
$171.84 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
47 |
43 |
$167.33 |
| 85379 |
|
15 |
14 |
$163.28 |
| A4216 |
Sterile water, saline and/or dextrose, diluent/flush, 10 ml |
14 |
13 |
$153.04 |
| 86140 |
|
28 |
28 |
$137.03 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12 |
12 |
$136.60 |
| 85730 |
|
13 |
12 |
$60.73 |
| 85651 |
|
13 |
13 |
$33.98 |
| 83540 |
|
13 |
12 |
$31.96 |
| G0008 |
Administration of influenza virus vaccine |
19 |
18 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
29 |
24 |
$0.00 |
| 90682 |
|
13 |
13 |
$0.00 |